Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.

Kuhn L, Wang C, Tsai WY, Wright TC, Denny L.

AIDS. 2010 Oct 23;24(16):2553-61. doi: 10.1097/QAD.0b013e32833e163e.

PMID:
20706107
2.

Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.

Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC Jr.

JAMA. 2005 Nov 2;294(17):2173-81.

PMID:
16264158
3.

Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.

Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Jr.

J Natl Cancer Inst. 2010 Oct 20;102(20):1557-67. doi: 10.1093/jnci/djq342. Epub 2010 Sep 30.

PMID:
20884893
4.

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J.

N Engl J Med. 2007 Oct 18;357(16):1589-97. Erratum in: N Engl J Med. 2008 Oct 9;359(15):1637. Johansson, Bo [added].

5.

The prevention of cervical cancer in HIV-infected women.

Franceschi S, Ronco G.

AIDS. 2010 Oct 23;24(16):2579-80. doi: 10.1097/QAD.0b013e32833f39b2. No abstract available.

PMID:
20940536
6.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

PMID:
19141778
7.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators.

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521
8.

Prevention of cervical cancer in women with HIV.

Heard I.

Curr Opin HIV AIDS. 2009 Jan;4(1):68-73. doi: 10.1097/COH.0b013e328319bcbe. Review.

PMID:
19339941
9.

From India to the world--a better way to prevent cervical cancer.

Schiffman M, Wacholder S.

N Engl J Med. 2009 Apr 2;360(14):1453-5. doi: 10.1056/NEJMe0901167. No abstract available.

10.

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.

PMID:
12359856
11.

Cervical neoplasia in the patient with HIV infection.

Stratton P, Ciacco KH.

Curr Opin Obstet Gynecol. 1994 Feb;6(1):86-91. Review.

PMID:
8180357
12.

HPV primary screening for cervical cancer: more pain than protection.

Davey DD, Armenti CA.

Diagn Cytopathol. 2000 Jun;22(6):333-5. No abstract available.

PMID:
10820524
13.

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R.

Rev Panam Salud Publica. 2004 Feb;15(2):75-89.

PMID:
15030652
14.

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.

Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC.

J Natl Cancer Inst. 2000 May 17;92(10):818-25.

PMID:
10814677
15.

Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.

Margolis KL, Carson LF, Setness PA, Stanley MW, Henry-Stanley MJ, Beneke J, Linzie B, McGlennen RC.

Arch Fam Med. 1999 Sep-Oct;8(5):433-9.

PMID:
10500518
16.

Screening for cervical cancer in high-risk populations: DNA pap test or Hybrid Capture II test alone?

Miranda Pereira SM, Castelo A, Makabe S, Utagawa ML, Di Loreto C, Sakamoto Maeda MY, Marques JA, Santoro CL, Filho AL, Das Dores GB.

Int J Gynecol Pathol. 2006 Jan;25(1):38-41.

PMID:
16306782
17.

Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.

Wensveen C, Kagie M, Veldhuizen R, De Groot C, Denny L, Zwinderman K, Trimbos B.

Acta Obstet Gynecol Scand. 2003 Sep;82(9):883-9.

PMID:
12911453
18.

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.

Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J; New Technologies for Cervical Cancer Working Group.

J Natl Cancer Inst. 2006 Jun 7;98(11):765-74.

PMID:
16757701
19.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

20.

Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.

Berkhof J, Meijer CJ.

N Engl J Med. 2008 Feb 7;358(6):642; author reply 643. No abstract available.

PMID:
18265441

Supplemental Content

Support Center